Orexigen Therapeutics, Inc. (OREX)
$6.87
-0.23 (-3.24%)
| CAPS Rating |
|
|---|---|
| Open | $7.05 |
| Previous Close | $7.10 |
| Daily Range | $6.82 - $7.21 |
| 52-Week Range | $1.55 - $10.83 |
| Market Cap | $323.17M |
| P/E Ratio | 5.91 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 943,050 |
| Average Daily Volume | 623,000 |
OREX
VS S&P 500 (SPY)
How do you think OREX will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
OREX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
OREX News and Commentary
- Orexigen obesity drug shows added benefits-studies – Reuters
- Tomorrow's Monster Stock? – The Motley Fool
- 3 Stocks in a Tailspin – The Motley Fool
- UPDATE 1-Orexigen says trial of 2nd obesity drug meets goal – Reuters
- Orexigen says trial of 2nd obesity drug meets goal – Reuters
- UPDATE 1-Orexigen to announce obesity drug data Wednesday – Reuters
- Up, Down, Up. Is This Stock a Home Run or Not? – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- A 1-in-100 Investor – The Motley Fool
Related News and Articles
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool
- This Stock Is a Train Wreck – The Motley Fool
- Drug Lowers Cholesterol; Stock Follows – The Motley Fool
- The Hottest Sector for 2010 – The Motley Fool
- Abbott: Brave or Stupid? – The Motley Fool
- 5-Star Stocks Poised to Pop: American Oriental Bioengineering – The Motley Fool
- Do You Have the Guts to Buy? – The Motley Fool
- This Top Stock Is a Winner – The Motley Fool
- Amylin Scores a Hat Trick – The Motley Fool
RSS Headlines
Fool UK
